290650.KQ KOE
L&C Bio Co., Ltd
1W: +13.8%
1M: +3.4%
3M: -40.8%
YTD: -40.5%
1Y: +58.2%
3Y: +52.8%
5Y: +62.0%
₩53,700.00 ($39.99)
-2600.00 (-4.62%)
Weekly Expected Move ±10.6%
₩42317
₩48009
₩53700
₩59391
₩65083
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$456.6B
-4.0% ▼
5Y CAGR: +41.5%
Total Liabilities
$248.1B
+37.2% ▲
5Y CAGR: +66.6%
Shareholders Equity
$198.2B
-30.3% ▼
5Y CAGR: +27.9%
Cash & Investments
$36.8B
+52.5% ▲
5Y CAGR: +6.1%
Total Debt
$92.2B
-25.6% ▼
5Y CAGR: +43.7%
Net Debt
$61.3B
-41.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $17.4B | $6.6B | $14.9B | $18.3B | $30.9B |
| Short-Term Investments | $2.2B | $5.7B | $44.2B | $5.9B | $5.9B |
| Cash & ST Investments | $19.6B | $12.3B | $59.2B | $24.1B | $36.8B |
| Net Receivables | $14.8B | $16.8B | $18.2B | $54.2B | $26.9B |
| Inventory | $12.3B | $34.2B | $46.3B | $46.8B | $42.8B |
| Other Current Assets | -$1K | $0 | $5.1B | $1.8B | $31.3B |
| Total Current Assets | $47.6B | $64.3B | $130.4B | $130.2B | $139.2B |
| Property, Plant & Equip. | $17.9B | $53.1B | $74.7B | $97.0B | $106.6B |
| Goodwill & Intangibles | $1.1B | $3.6B | $1.5B | $199.2B | $127.8B |
| Long-Term Investments | $38.9B | $76.6B | $48.8B | $24.7B | $46.0B |
| Other Non-Current Assets | $0 | $0 | $6.9B | $15.7B | $4.5B |
| Total Non-Current Assets | $59.8B | $135.4B | $131.9B | $345.4B | $317.4B |
| Total Assets | $107.4B | $199.7B | $262.2B | $475.6B | $456.6B |
| — Liabilities — | |||||
| Accounts Payable | $1.0B | $2.9B | $1.7B | $2.3B | $1.4B |
| Short-Term Debt | $126M | $9.7B | $79.3B | $98.6B | $84.0B |
| Deferred Revenue | $629M | $310M | $0 | $0 | $80M |
| Other Current Liabilities | $3.1B | $3.8B | $19.4B | $4.9B | $151.3B |
| Total Current Liabilities | $5.6B | $18.7B | $101.8B | $154.7B | $237.8B |
| Long-Term Debt | $5.4B | $70.6B | $541M | $20.1B | $4.0B |
| Other Non-Current Liab. | $1.2B | $1.3B | $1.2B | $2.1B | $1.8B |
| Total Non-Current Liabilities | $8.5B | $73.2B | $3.5B | $26.2B | $10.3B |
| Total Liabilities | $14.1B | $91.9B | $105.4B | $180.9B | $248.1B |
| — Equity — | |||||
| Common Stock | $11.4B | $11.4B | $11.4B | $11.4B | $12.4B |
| Retained Earnings | $33.3B | $36.9B | $83.4B | $222.2B | $96.7B |
| Accumulated OCI | $2.8B | $4.1B | $2.4B | $1.2B | $19.2B |
| Total Stockholders Equity | $85.0B | $98.0B | $146.9B | $284.4B | $198.2B |
| Total Liabilities & Equity | $107.4B | $199.7B | $262.2B | $475.6B | $456.6B |
| — Key Metrics — | |||||
| Total Debt | $6.8B | $81.9B | $82.1B | $123.9B | $92.2B |
| Net Debt | -$10.6B | $75.4B | $67.2B | $105.6B | $61.3B |
| Total Investments | $41.2B | $82.3B | $93.1B | $30.5B | $51.9B |